AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$630M |
| 2 |
Visa
V
|
+$363M |
| 3 |
MSCI
MSCI
|
+$322M |
| 4 |
Walt Disney
DIS
|
+$297M |
| 5 |
Monster Beverage
MNST
|
+$281M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$584M |
| 2 |
Nike
NKE
|
+$573M |
| 3 |
Meta Platforms (Facebook)
META
|
+$489M |
| 4 |
Adobe
ADBE
|
+$418M |
| 5 |
Advanced Micro Devices
AMD
|
+$416M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.76% |
| 2 | Healthcare | 17.68% |
| 3 | Financials | 13.09% |
| 4 | Consumer Discretionary | 10.62% |
| 5 | Industrials | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Dollar General
DG
$28.1B
| $341M | 0.17% |
1,422,409
+1,094,109
| +333% | +$270M |
|
127
iShares Gold Trust
IAU
$63.8B
| $341M | 0.16% |
10,801,250
-343,282
| -3% | -$11.2M |
|
128
Humana
HUM
$44B
| $335M | 0.16% |
690,487
-247,772
| -26% | -$121M |
|
129
Align Technology
ALGN
$12.4B
| $334M | 0.16% |
1,611,557
-294,677
| -15% | -$75.9M |
|
130
Aflac
AFL
$64.8B
| $333M | 0.16% |
5,926,224
-43,314
| -0.7% | -$2.55M |
|
131
iShares Russell 1000 Value ETF
IWD
$81.8B
| $329M | 0.16% |
2,417,109
+93,956
| +4% | +$14.1M |
|
132
Intuit
INTU
$86.3B
| $328M | 0.16% |
846,583
+135,465
| +19% | +$58.5M |
|
133
Applied Materials
AMAT
$398B
| $326M | 0.16% |
3,973,344
-185,226
| -4% | -$17.9M |
|
134
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
| $325M | 0.16% |
4,004,770
+355,551
| +10% | +$29.3M |
|
135
ASML
ASML
$634B
| $320M | 0.15% |
769,867
-41,927
| -5% | -$21M |
|
136
Cigna
CI
$76.1B
| $319M | 0.15% |
1,151,349
-23,728
| -2% | -$6.68M |
|
137
Hexcel
HXL
$7.76B
| $319M | 0.15% |
6,160,587
+2,263,252
| +58% | +$132M |
|
138
Trex
TREX
$4.56B
| $314M | 0.15% |
7,157,362
-1,808,661
| -20% | -$96.8M |
|
139
Booking.com
BKNG
$150B
| $301M | 0.15% |
4,576,500
-2,582,850
| -36% | -$194M |
|
140
CVS Health
CVS
$134B
| $301M | 0.15% |
3,152,258
+448,240
| +17% | +$44.4M |
|
141
Illumina
ILMN
$31B
| $300M | 0.15% |
1,618,546
+690,263
| +74% | +$137M |
|
142
Norfolk Southern
NSC
$75B
| $299M | 0.14% |
1,424,173
-16,620
| -1% | -$4M |
|
|
ABMD
143
DELISTED
Abiomed Inc
ABMD
| $295M | 0.14% |
1,202,638
+22,726
| +2% | +$6.14M |
|
144
Dover
DOV
$27.5B
| $292M | 0.14% |
2,501,261
+436,060
| +21% | +$55.7M |
|
|
SRCL
145
DELISTED
Stericycle Inc
SRCL
| $288M | 0.14% |
6,838,679
+88,561
| +1% | +$4.26M |
|
146
Union Pacific
UNP
$172B
| $285M | 0.14% |
1,460,642
-398,891
| -21% | -$88.3M |
|
147
iShares Core MSCI Emerging Markets ETF
IEMG
$149B
| $281M | 0.14% |
6,527,979
+256,282
| +4% | +$12.3M |
|
148
Parker-Hannifin
PH
$121B
| $276M | 0.13% |
1,140,558
-34,366
| -3% | -$9.3M |
|
149
Steris
STE
$22.5B
| $275M | 0.13% |
1,654,834
-12,214
| -0.7% | -$2.49M |
|
150
Morgan Stanley
MS
$330B
| $269M | 0.13% |
3,399,486
-190,569
| -5% | -$16.1M |
|
Similar funds
AllianceBernstein's Q3 2022 Portfolio in Review
As of Q3 2022, AllianceBernstein held 3,359 positions worth $207B, down 5.7% from $219B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
AllianceBernstein's Q3 2022 filing shows 102 new, 1,361 increased, 1,417 reduced and 89 closed positions. Its largest new stake was Genmab: 5,779,489 shares worth $186M. The largest sale was Qualcomm, an estimated $584M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- AllianceBernstein's largest Q3 2022 buy was Genmab: 5,779,489 shares worth $186M.
- AllianceBernstein added most to iShares Russell 1000 Growth ETF in Q3 2022, an estimated $630M increase.
- AllianceBernstein's biggest Q3 2022 reduction was Qualcomm, cutting an estimated $584M.
- AllianceBernstein fully exited American Campus Communities, Inc. in Q3 2022, selling an estimated $244M.
- AllianceBernstein's ten largest holdings make up 23% of its $207B portfolio in Q3 2022.
- AllianceBernstein opened 102 new positions and closed 89 in Q3 2022.
- AllianceBernstein's portfolio value fell 5.7% quarter-over-quarter to $207B.
Based on AllianceBernstein's 13F filing for Q3 2022, filed 15 Nov 2022.